Thomas A Fitzgerald - Net Worth and Insider Trading
Thomas A Fitzgerald Net Worth
The estimated net worth of Thomas A Fitzgerald is at least $548 dollars as of 2024-11-13. Thomas A Fitzgerald is the CFO of TransCode Therapeutics Inc and owns about 1,408 shares of TransCode Therapeutics Inc (RNAZ) stock worth over $548. Details can be seen in Thomas A Fitzgerald's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Thomas A Fitzgerald has not made any transactions after 2023-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Thomas A Fitzgerald
Thomas A Fitzgerald Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas A Fitzgerald owns 1 companies in total, including TransCode Therapeutics Inc (RNAZ) .
Click here to see the complete history of Thomas A Fitzgerald’s form 4 insider trades.
Insider Ownership Summary of Thomas A Fitzgerald
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RNAZ | TransCode Therapeutics Inc | 2023-09-28 | director & VP & Chief Financial Officer |
Thomas A Fitzgerald Latest Holdings Summary
Thomas A Fitzgerald currently owns a total of 1 stock. Thomas A Fitzgerald owns 1,408 shares of TransCode Therapeutics Inc (RNAZ) as of September 28, 2023, with a value of $548.
Latest Holdings of Thomas A Fitzgerald
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics Inc | 2023-09-28 | 1,408 | 0.39 | 548 |
Holding Weightings of Thomas A Fitzgerald
Thomas A Fitzgerald Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas A Fitzgerald has made a total of 1 transactions in TransCode Therapeutics Inc (RNAZ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TransCode Therapeutics Inc is the acquisition of 1,234 shares on September 28, 2023, which cost Thomas A Fitzgerald around $25,169.
Insider Trading History of Thomas A Fitzgerald
- 1
Thomas A Fitzgerald Trading Performance
GuruFocus tracks the stock performance after each of Thomas A Fitzgerald's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas A Fitzgerald is -70.26%. GuruFocus also compares Thomas A Fitzgerald's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas A Fitzgerald within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas A Fitzgerald's insider trading performs compared to the benchmark.
Performance of Thomas A Fitzgerald
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -43.32 | | | | | |
| Relative Return to S&P 500(%) | -39.08 | | | | | |
Thomas A Fitzgerald Ownership Network
Ownership Network List of Thomas A Fitzgerald
Ownership Network Relation of Thomas A Fitzgerald
Thomas A Fitzgerald Owned Company Details
What does TransCode Therapeutics Inc do?
Who are the key executives at TransCode Therapeutics Inc?
Thomas A Fitzgerald is the director & VP & Chief Financial Officer of TransCode Therapeutics Inc. Other key executives at TransCode Therapeutics Inc include director & 10 percent owner & Chief Executive Officer Robert Michael Dudley , 10 percent owner Anna Moore , and 10 percent owner Zdravka Medarova .
TransCode Therapeutics Inc (RNAZ) Insider Trades Summary
Over the past 18 months, Thomas A Fitzgerald made 1 insider transaction in TransCode Therapeutics Inc (RNAZ) with a net purchase of 49,350. Other recent insider transactions involving TransCode Therapeutics Inc (RNAZ) include a net purchase of 154,607 shares made by Robert Michael Dudley ,
In summary, during the past 3 months, insiders sold 0 shares of TransCode Therapeutics Inc (RNAZ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TransCode Therapeutics Inc (RNAZ) were sold and 5,099 shares were bought by its insiders, resulting in a net purchase of 5,099 shares.
TransCode Therapeutics Inc (RNAZ)'s detailed insider trading history can be found in Insider Trading Tracker table.
TransCode Therapeutics Inc Insider Transactions
Thomas A Fitzgerald Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas A Fitzgerald. You might contact Thomas A Fitzgerald via mailing address: C/o Transcode Therapeutics, Inc., 6 Liberty Square, #2382, Boston Ma 02109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
